MOH — authorised 28 February 2001
- Marketing authorisation holder: JANSSEN PHARMS
- Status: likely_approved
🇮🇱 Razadyne in Israel
MOH authorised Razadyne on 28 February 2001
Marketing authorisation
Razadyne in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Israel
Frequently asked questions
Is Razadyne approved in Israel?
Yes. MOH authorised it on 28 February 2001.
Who is the marketing authorisation holder for Razadyne in Israel?
JANSSEN PHARMS holds the Israeli marketing authorisation.